INVO Fertility, Inc.
NCM: IVFLive Quote
About INVO Fertility, Inc.
Healthcare
Medical Devices
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
📊 Fundamental Analysis
INVO Fertility, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported 22.6% revenue growth, which is well above average for the Healthcare sector.
At a current price of $2.01, IVF currently trades near the bottom of its 52-week range (0%), indicating potential value or weakness (Range: $1.92 - $384.00).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
Key Financials
Market Cap
$2.50M
Trailing P/E
--
Forward P/E
-0.09
Beta (5Y)
--
52W High
$384.00
52W Low
$1.92
Avg Volume
1.46M
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App